Pamidronate Disodium
NDC 61703-326, PAMIDRONATE DISODIUM, injection, solution, from Hospira, Inc..
- Product NDC
- 61703-326
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075841
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61703-326 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PAMIDRONATE DISODIUM9 mg/mL
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61703-326-18 | 61703032618 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-326-18) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9b6a9a3b-71c9-4dcb-b857-5d1de25c3a23Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=61703-326
Use it
Look up 61703-326 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61703-326 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61703-326. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.